Request Discount

Cardiopulmonary Stress Testing Systems Market (Product - Pulse Oximeter, Stress Blood Pressure Monitor, and Stress ECG; Application - Preoperative Evaluation, and Stress Testing In Sports; End User - Hospitals, Clinical Diagnostic Labs, and Rehab Centers): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : February, 2020

  • Rep Id : HC0790

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Cardiopulmonary Stress Testing Systems Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Cardiopulmonary Stress Testing Systems Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Cardiopulmonary Stress Testing Systems Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on the cardiopulmonary stress testing systems market provides an in-depth analysis of segments and sub-segments in the global as well as regional cardiopulmonary stress testing systems market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional cardiopulmonary stress testing systems market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global cardiopulmonary stress testing systems market. According to the report, the global cardiopulmonary stress testing systems market is projected to grow at a CAGR of 4.6% over the forecast period of 2019-2025.

 

Market Insight

The Cardiopulmonary Stress test is an evaluation of the cardiopulmonary system measuring the integrated response of the pulmonary, cardiovascular, and muscular systems, which involves measurements of gas exchange, primarily oxygen uptake (i.e., VO2), carbon dioxide output (VCO2), minute ventilation, and anaerobic (lactic acid) threshold. It has become an important clinical tool for the assessment of patients with cardiovascular and pulmonary disease. The test is performed to a point of symptom limitation (chest pain, severe dyspnea, pallor, faintness, inability to continue pedaling or walking) or discontinued by medical staff in case of significant ECG abnormalities, fall in systolic or diastolic blood pressure (BP), severe oxygen desaturation (<80%), or achievement of maximum predicted heart rate. The cardiopulmonary exercise the testing system is increasingly being used in a wide spectrum of clinical applications for the evaluation of the undiagnosed exercise.

 

As per WHO, approximately 17.9 million people die every year due to cardiovascular diseases. The increasing cardiovascular and pulmonary disorders are driving the cardiopulmonary stress testing systems market. On the other hand, according to the Global Health and Wellness Report - 2018, 40% of the USA adult population has been diagnosed with a cardiovascular condition, which increases the demand for the market. Technology is enhancing at a rapid speed where many systems have been revolutionized with the latest technological advancement, which makes the cardiopulmonary stress testing systems more accurate, valuable and reliable. This technological development propels the market. On the other hand, the increasing number of approval of the new product by the government authorities propel the growth of this market. For instance, Vyaire Medical Inc has received FDA approval for its two Novel Pulmonary Function Testing Products which runs on the easy-to-operate Sentry Suite Software, that is Vyntus ONE and Vyntus BODY. The products offer consistent and accurate respiratory testing that has attracted the attention of customers. However, the high-cost associated with the cardiopulmonary Stress test system yet remains one of the major restraints for this market. Moreover, government initiatives and the manufacturer's approach towards advanced technology offer favorable opportunities in the cardiopulmonary stress testing systems market.

 

Based on the region, the global cardiopulmonary stress testing systems market is segmented into North America, Asia Pacific, Europe, and ROW. Among all, North America holds the highest market share and expected to continue its growth in the forecast period due to the increasing adoption of early diagnosis practices as well as rising adoption of newly introduced advanced systems at public health institutes which aid physicians and nurses to monitor patient’s health in real-time. In addition, the increasing number of cardiovascular disease patients in this region boost the growth of this market. On the other hand, Asia Pacific is expected to hold the highest market share in this market due to the increasing air pollution has resulted in an exponential increase in respiratory and cardiovascular diseases.

 

Segment Covered

The report on the global cardiopulmonary stress testing systems market covers segments such as product, application, and end user. On the basis of product, the sub-markets include a pulse oximeter, stress blood pressure monitor, and stress ECG. On the basis of application, the sub-markets include preoperative evaluation, and stress testing in sports. On the basis of end user, the sub-markets include hospitals, clinical diagnostic labs, and rehab centers.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Thermo Fisher Scientific Ltd, Philips Healthcare, Care Medical Ltd, Cosmed Medical, Cardiac Science Corporation, GE Healthcare, TouchPoint, Cardinal Health, NIHON KOHDEN CORPORATION, Vyaire Medical Inc., and W.L. Gore & Associates.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of cardiopulmonary stress testing systems market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount